Immune-active polymeric materials for the treatment of inflammatory diseases

Pahwa, 2023 Brusini, 2020, Advanced nanomedicines for the treatment of inflammatory diseases, Adv Drug Deliv Rev, 157, 161, 10.1016/j.addr.2020.07.010 Ferreira, 2018, The role of natural-based biomaterials in advanced therapies for autoimmune diseases, Adv Exp Med Biol, 127–46, 10.1007/978-981-13-0947-2_8 Kaur, 2019, Innate immunity, Pediatr Clin, 66, 905 Nakkala, 2021, Immunomodulatory biomaterials and their application in therapies for chronic inflammation-related diseases, Acta Biomater, 123, 1, 10.1016/j.actbio.2021.01.025 Stein, 1992, Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation, J Exp Med, 176, 287, 10.1084/jem.176.1.287 Rayahin, 2015, High and low molecular weight hyaluronic acid differentially influence macrophage activation, ACS Biomater Sci Eng, 1, 481, 10.1021/acsbiomaterials.5b00181 Whitaker, 2021, Immunomodulatory biomaterials for tissue repair, Chem Rev, 121, 11305, 10.1021/acs.chemrev.0c00895 Kotsias, 2019, Antigen processing and presentation, Int Rev Cell Mol Biol, 348, 69, 10.1016/bs.ircmb.2019.07.005 Mansurov, 2021, Immunoengineering approaches for cytokine therapy, Am J Physiol Cell Physiol, 321, C369, 10.1152/ajpcell.00515.2020 Vazquez, 2015, B cells responses and cytokine production are regulated by their immune microenvironment, Cytokine, 74, 318, 10.1016/j.cyto.2015.02.007 Tabas, 2013, Anti-inflammatory therapy in chronic disease: challenges and opportunities, Science, 339, 166, 10.1126/science.1230720 Browne, 2015, Biomaterial-mediated modification of the local inflammatory environment, Front Bioeng Biotechnol, 3, 10.3389/fbioe.2015.00067 Tu, 2022, Design of therapeutic biomaterials to control inflammation, Nat Rev Mater, 7, 557, 10.1038/s41578-022-00426-z Mariani, 2019, Biomaterials: foreign bodies or tuners for the immune response?, IJMS, 20, 636, 10.3390/ijms20030636 Badylak, 2021 Andorko, 2017, Designing biomaterials with immunomodulatory properties for tissue engineering and regenerative medicine, Bioeng Transl Med, 2, 139, 10.1002/btm2.10063 Wang, 2021, Update on nanoparticle-based drug delivery system for anti-inflammatory treatment, Front Bioeng Biotechnol, 9 Garash, 2016, Drug delivery strategies to control macrophages for tissue repair and regeneration, Exp Biol Med (Maywood, NJ, U S), 241, 1054, 10.1177/1535370216649444 Deng, 2021, Inflammation-responsive delivery systems for the treatment of chronic inflammatory diseases, Drug Deliv Transl Res, 11, 1475, 10.1007/s13346-021-00977-8 Lee, 2011, Nucleic acid-binding polymers as anti-inflammatory agents, Proc Natl Acad Sci USA, 108, 14055, 10.1073/pnas.1105777108 Duvvuri, 2019, Cell-free DNA as a biomarker in autoimmune rheumatic diseases, Front Immunol, 10, 502, 10.3389/fimmu.2019.00502 Kubiritova, 2019, Cell-free nucleic acids and their emerging role in the pathogenesis and clinical management of inflammatory bowel disease, IJMS, 20, 3662, 10.3390/ijms20153662 Műzes, 2022, Cell-free DNA in the pathogenesis and therapy of non-infectious inflammations and tumors, Biomedicines, 10, 2853, 10.3390/biomedicines10112853 Genito, 2020, Considerations for size, surface charge, polymer degradation, co-delivery, and manufacturability in the development of polymeric particle vaccines for infectious diseases, Advanced NanoBiomed Research, 1 Fromen, 2015, Controlled analysis of nanoparticle charge on mucosal and systemic antibody responses following pulmonary immunization, Proc Natl Acad Sci USA, 112, 488, 10.1073/pnas.1422923112 Wen, 2016, Switching the immunogenicity of peptide assemblies using surface properties, ACS Nano, 10, 9274, 10.1021/acsnano.6b03409 Seong, 2004, Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses, Nat Rev Immunol, 4, 469, 10.1038/nri1372 Moyano, 2012, Nanoparticle hydrophobicity dictates immune response, J Am Chem Soc, 134, 3965, 10.1021/ja2108905 Lin, 2021, Reactive oxygen species in autoimmune cells: function, differentiation, and metabolism, Front Immunol, 12 DeJulius, 2021, Optimizing an antioxidant TEMPO copolymer for reactive oxygen species scavenging and anti-inflammatory effects in vivo, Bioconjugate Chem, 32, 928, 10.1021/acs.bioconjchem.1c00081 Seah, 2018, Cancer-targeted reactive oxygen species-degradable polymer nanoparticles for near infrared light-induced drug release, J Mater Chem B, 6, 7737, 10.1039/C8TB02323A Li, 2018, Mitigation of inflammatory immune responses with hydrophilic nanoparticles, Angew Chem, 130, 4617, 10.1002/ange.201710068 Suzuki, 2021, Host-microbe cross-talk governs amino acid chirality to regulate survival and differentiation of B cells, Sci Adv, 7, 10.1126/sciadv.abd6480 Azam, 2021, Introduction of non-natural amino acids into T-cell epitopes to mitigate peptide-specific T-cell responses, Front Immunol, 12, 10.3389/fimmu.2021.637963 Wang, 2019, Chiral polypeptide thermogels induce controlled inflammatory response as potential immunoadjuvants, ACS Appl Mater Interfaces, 11, 8725, 10.1021/acsami.9b01872 Griffin, 2021, Activating an adaptive immune response from a hydrogel scaffold imparts regenerative wound healing, Nat Mater, 20, 560, 10.1038/s41563-020-00844-w Griffin, 2015, Accelerated wound healing by injectable microporous gel scaffolds assembled from annealed building blocks, Nat Mater, 14, 737, 10.1038/nmat4294 Liu, 2023, A balance between pro-inflammatory and pro-reparative macrophages is observed in regenerative D-MAPS, Adv Sci, 10 Abatangelo, 2020, Hyaluronic acid: redefining its role, Cells, 9, 1743, 10.3390/cells9071743 Camara, 2021, Hyaluronic acid—dexamethasone nanoparticles for local adjunct therapy of lung inflammation, IJMS, 22 Xiang, 2006, Pathogen recognition and development of particulate vaccines: does size matter?, Methods, 40, 1, 10.1016/j.ymeth.2006.05.016 Nicolete, 2011, The uptake of PLGA micro or nanoparticles by macrophages provokes distinct in vitro inflammatory response, Int Immunopharm, 11, 1557, 10.1016/j.intimp.2011.05.014 Da Silva, 2009, Chitin is a size-dependent regulator of macrophage TNF and IL-10 production, J Immunol, 182, 3573, 10.4049/jimmunol.0802113 Liu, 2023, Spatial confinement modulates macrophage response in microporous annealed particle (MAP) scaffolds, Adv Healthcare Mater Sridharan, 2019, Material stiffness influences the polarization state, function and migration mode of macrophages, Acta Biomater, 89, 47, 10.1016/j.actbio.2019.02.048 Woods, 2022, Biomimetic scaffolds for spinal cord applications exhibit stiffness-dependent immunomodulatory and neurotrophic characteristics, Adv Healthcare Mater, 11, 10.1002/adhm.202101663 Getts, 2014, Therapeutic inflammatory monocyte modulation using immune-modifying microparticles, Sci Transl Med, 6, 10.1126/scitranslmed.3007563 Saito, 2019, Designing drug-free biodegradable nanoparticles to modulate inflammatory monocytes and neutrophils for ameliorating inflammation, J Contr Release, 300, 185, 10.1016/j.jconrel.2019.02.025 Liang, 2018, Cationic nanoparticle as an inhibitor of cell-free DNA-induced inflammation, Nat Commun, 9, 4291, 10.1038/s41467-018-06603-5 Shi, 2022, A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease, Sci Adv, 8, 10.1126/sciadv.abj2372 Caminade, 2022, Curing inflammatory diseases using phosphorous dendrimers, WIREs Nanomed Nanobiotechnol, 14, 10.1002/wnan.1783 Fruchon, 2017, Pro-inflammatory versus anti-inflammatory effects of dendrimers: the two faces of immuno-modulatory nanoparticles, Nanomaterials, 7, 251, 10.3390/nano7090251 Shaunak, 2004, Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation, Nat Biotechnol, 22, 977, 10.1038/nbt995 Chauhan, 2009, Unexpected in vivo anti-inflammatory activity observed for simple, surface functionalized poly(amidoamine) dendrimers, Biomacromolecules, 10, 1195, 10.1021/bm9000298 Fruchon, 2018, The ABP dendrimer, a drug-candidate against inflammatory diseases that triggers the activation of interleukin-10 producing immune cells, Molecules, 23, 1272, 10.3390/molecules23061272 Hayder, 2015, Phosphorus-based dendrimer ABP treats neuroinflammation by promoting IL-10-producing CD4 + T cells, Biomacromolecules, 16, 3425, 10.1021/acs.biomac.5b00643 Hayder, 2011, A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis, Sci Transl Med, 3, 10.1126/scitranslmed.3002212 Jebbawi, 2020, An anti-inflammatory poly(PhosphorHydrazone) dendrimer capped with AzaBisPhosphonate groups to treat psoriasis, Biomolecules, 10, 949, 10.3390/biom10060949 Jiang, 2022, Bioinspired design of mannose-decorated globular lysine dendrimers promotes diabetic wound healing by orchestrating appropriate macrophage polarization, Biomaterials, 280, 10.1016/j.biomaterials.2021.121323 Jalilian, 2012, Glatiramer Acetate in treatment of multiple sclerosis: a toolbox of random co-polymers for targeting inflammatory mechanisms of both the innate and adaptive immune system?, Int J Mol Sci, 13, 14759, 10.3390/ijms131114579 Prod’homme, 2019, The evolving mechanisms of action of glatiramer acetate, Cold Spring Harb Perspect Med, 9, a029249, 10.1101/cshperspect.a029249 Votaw, 2021, Randomized peptide assemblies for enhancing immune responses to nanomaterials, Biomaterials, 273, 10.1016/j.biomaterials.2021.120825 Erzina, 2021, An immunomodulatory peptide dendrimer inspired from glatiramer acetate, Angew Chem, 133, 26607, 10.1002/ange.202113562 Rudra, 2010, A self-assembling peptide acting as an immune adjuvant, Proc Natl Acad Sci USA, 107, 622, 10.1073/pnas.0912124107 Kelly, 2017, Biomaterial strategies for generating therapeutic immune responses, Adv Drug Deliv Rev, 114, 3, 10.1016/j.addr.2017.04.009 Chen, 2013, The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation, Biomaterials, 34, 8776, 10.1016/j.biomaterials.2013.07.063 Kelly, 2022, A sublingual nanofiber vaccine to prevent urinary tract infections, Sci Adv, 8, 10.1126/sciadv.abq4120 Hudalla, 2014, Gradated assembly of multiple proteins into supramolecular nanomaterials, Nat Mater, 13, 829, 10.1038/nmat3998 Fries, 2021, HIV envelope antigen valency on peptide nanofibers modulates antibody magnitude and binding breadth, Sci Rep, 11, 10.1038/s41598-021-93702-x Mora-Solano, 2017, Active immunotherapy for TNF-mediated inflammation using self-assembled peptide nanofibers, Biomaterials, 149, 1, 10.1016/j.biomaterials.2017.09.031 Shores, 2020, Multifactorial design of a supramolecular peptide anti-IL-17 vaccine toward the treatment of psoriasis, Front Immunol, 11, 1855, 10.3389/fimmu.2020.01855 Ghoreschi, 2021, Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis, Lancet, 397, 754, 10.1016/S0140-6736(21)00184-7 Hainline, 2021, Modular complement assemblies for mitigating inflammatory conditions, Proc Natl Acad Sci USA, 118, 10.1073/pnas.2018627118 Vincent, 2021, The combination of morphology and surface chemistry defines the immunological identity of nanocarriers in human blood, Adv Therap, 4, 10.1002/adtp.202100062 Chen, 2021, Polyethylene glycol immunogenicity: theoretical, clinical, and practical aspects of anti-polyethylene glycol antibodies, ACS Nano, 15, 14022, 10.1021/acsnano.1c05922 Sellaturay, 2021, Polyethylene glycol–induced systemic allergic reactions (anaphylaxis), J Allergy Clin Immunol Pract, 9, 670, 10.1016/j.jaip.2020.09.029 Maltezou, 2022, Anaphylaxis rates associated with COVID-19 vaccines are comparable to those of other vaccines, Vaccine, 40, 183, 10.1016/j.vaccine.2021.11.066